<DOC>
	<DOCNO>NCT00295750</DOCNO>
	<brief_summary>The study three-arm , active-control , multi-centre , parallel group study .</brief_summary>
	<brief_title>The Efficacy Safety Degarelix One Month Dosing Regimens Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>Main Patients , age 18 year , histologically proven prostate cancer stag endocrine treatment indicate . Baseline testosterone &gt; 1.5 ng/mL . Life expectancy least 12 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Prostate Cancer</keyword>
</DOC>